(a) The dosage instruction for the elixir were to "take 2 to 3 teaspoons in water every four hours" Assume each teaspoon was pure DEG, and estimate the volume (ml) of DEG a patient would have consumed in a day.
Answers: 1 tea spoon measure of 5 ml
number of dosages taken by patient as prescribed in 1 day = 24/4 = 6 dosages
Each dose = 10 to 15 ml (i.e equivalent to 2 to 3 tea spoons)
So volume of drug that taken by a patient in a day = 60 to 90 ml / day
(b) The lethal oral dose of Diethylene glycol(DEG) has been estimated to be 1.4 ml DEG per kg of body mass. Determine the maximum patient mass (lbm) for which the daily dose estimated in part (a) would be fatal. If you need values of quantities you cannot find in this text, use the internet. Suggest three reasons why the dose could be dangerous to a patient whose mass is well above the calculated value.
Answer: The dose = 60 to 90 ml
So maximum patient mass for which the daily dose would be fatal
= 60 / 1.4 = 42.8 kg and 90/ 1.4 = 64.28 kg
(c) Estimate how many people would have been poisoned if the total production of the drug had been consumed.
Answer :
If the total product has been consumed and the average mass of human being = 65 kg [assume 65 kg is the avg. mass of human body as average weight is not given]
So consumption by one human = 65 X 1.4 = 91 ml
240 gallons = 3785.41 X 240 ml = 907538.4 ml ( as 240 gallons of Salfanilamide in DEG were manufactured)
Number of human that will consume the drug = 907538.4 / 91 = 9972.94 i.e. = 9973 (approx) people would have been poisoned if total production of the drug had been consumed.
(d) List steps the company should have taken that would
have prevented this tragedy .
Answer:
1. The company should give the dosage value on the medicine packaging
2. There should be well awareness about the lethal effects if excess dose is taken
3. There should be good screening of the drug before commercialisation of the medicine
2.19. During the early part of the 20th century, sulfanilamide (an al drug g) was only...
Please read the following article: Your Google Searches Could Help the FDA Find Drug Side Effects The Food and Drug Administration is talking to Google about how the search engine could help the agency identify previously unknown side effects of medications. Agency officials held a conference call on June 9 with a senior Google researcher who co-wrote a 2013 paper about using search query data to identify adverse drug reactions, according to a record of the meeting posted to the...
Please, can you provide a one-page answer to question number 3! This component is essential! unheuser has strugsled with slow growth of t Market Senacthure Monopoly and Monopoistic Competition 221 ket beers in recent years. U.S. sales laws in its efforts to prevent an Israeli company from successfully selling a generie version of its cholesterol medicine, TriCor. Drug companies usually have three to 10 years of exclusive patent rights remaining when their products hit the market. However, they can often...
Hello I need question 3 with 3/4 of a page. There are two documents as you will see. unheuser has strugsled with slow growth of t Market Senacthure Monopoly and Monopoistic Competition 221 ket beers in recent years. U.S. sales laws in its efforts to prevent an Israeli company from successfully selling a generie version of its cholesterol medicine, TriCor. Drug companies usually have three to 10 years of exclusive patent rights remaining when their products hit the market. However,...
Please read the article bellow and discuss the shift in the company's approach to genetic analysis. Please also discuss what you think about personal genomic companies' approaches to research. Feel free to compare 23andMe's polices on research with another company's. Did you think the FDA was right in prohibiting 23andMe from providing health information? These are some sample talking points to get you thinking about the ethics of genetic research in the context of Big Data. You don't have to...
10. Write a one-page summary of the attached paper? INTRODUCTION Many problems can develop in activated sludge operation that adversely affect effluent quality with origins in the engineering, hydraulic and microbiological components of the process. The real "heart" of the activated sludge system is the development and maintenance of a mixed microbial culture (activated sludge) that treats wastewater and which can be managed. One definition of a wastewater treatment plant operator is a "bug farmer", one who controls the aeration...